BIIB vs WAT
Biogen vs Waters Corporation — AI-powered side-by-side comparison
VS
WAT
Waters Corporation
70
Buy
| Metric | BIIB | WAT |
|---|
| AI Score |
67
|
70
|
| Price |
$208.02
|
$406.91
|
| P/E Ratio |
36.61×
|
101.21×
|
| ROE |
7.1%
|
25.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
67.7%
|
50.8%
|
| Debt / Equity |
0.44×
|
0.33×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
56.7
|
75.0
|
| Beta |
0.158
|
1.202
|
| Expected Upside |
+5.2%
|
+0.2%
|
AI Committee View
Current Innellis committee reasoning for BIIB versus WAT.
WAT leads by 3 points.
WAT scores 70/100 (Buy) versus BIIB at 67/100 (Buy).
BIIB Committee View
80% agreement
5 analysts
The primary driver is news sentiment is positive (+0.42 across 47 articles, 14d). The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
WAT Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 75 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- RSI at 75 is in overbought territory — Technical
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical